A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.

Source:http://linkedlifedata.com/resource/pubmed/id/2632271

Download in:

View as

General Info

PMID
2632271